Alzamend Neuro, Inc.
Pharmaceutical company · Atlanta, Georgia, United States · Nasdaq: ALZN
Alzamend Neuro, Inc. is a pharmaceutical company headquartered in Atlanta, Georgia, United States. Its earliest recorded incorporation is in 2016. Its shares trade on Nasdaq under the ticker ALZN. It has reported private securities offerings to the US SEC, most recently $231,519 sold in a notice filed in 2019.
Alzamend Neuro at a glance
What does Alzamend Neuro do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $231,519 sold (2019).
Frequently asked questions about Alzamend Neuro
Where is Alzamend Neuro headquartered?
Alzamend Neuro, Inc. is headquartered in Atlanta, Georgia, United States.
What does Alzamend Neuro do?
Alzamend Neuro, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Alzamend Neuro a public company?
Yes. Alzamend Neuro, Inc. trades on Nasdaq under the ticker ALZN.
When was Alzamend Neuro founded?
The earliest incorporation on record for Alzamend Neuro, Inc. is in 2016, according to public company registers.
Similar companies
- Vero Biotech Inc.Atlanta, Georgia, United States
- Trevena IncAtlanta, Georgia, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences